AI-Driven Drug Discovery Platforms Market Disruption.

AI Drug DiscoveryBiotechnology TrendsData IntegrationPharmaceutical InnovationRegulatory Compliance

This report delves into how AI is reshaping global drug discovery processes from 2024 to 2030. It highlights the transition from traditional to AI-enabled workflows, focusing on efficiency gains and regional adoption. The document explores the role of AI in target identification, lead optimization, and regulatory compliance. It also examines partnerships among pharma companies, technology providers, and emerging tech landscapes, emphasizing the strategic implications of AI advancements.

Researcher

Anagha Nikam, Ghost Research

PublishedFebruary 2026

Perspective.

PurposeTo explore the transformative impact of AI on the global drug discovery market.

AudiencePharmaceutical and biotech companies, technology providers, investors, and regulatory bodies.

Special EmphasisInnovation, technology adoption, economic impact, and regulatory trends.

155Pages of Deep Analysis

111Curated Credible Sources

24Proprietary AI Visuals

33Data Analysis Tables

$495

Anagha Nikam

7+ Years of Experience

Sectors & Industries

Consumer StaplesEnergyHealth Care

Functions & Expertise

Market IntelligenceData & AI

Have questions? Our Research Desk is here to help

Top Insights.

AI is revolutionizing drug discovery with efficiency and accuracy.Collaboration and data sharing are central to competitive advantage.Robotics and multimodal models are integrating into AI platforms.Regulatory clarity is impacting AI adoption across regions.Investment trends highlight value in platform and data capabilities.

Key Questions Answered.

155Pages of Deep Analysis

24Proprietary AI Visuals

111Curated Credible Sources

33Data Analysis Tables

Summary.

AI-driven drug discovery is projected to grow, with the market reaching $9.1 billion by 2030 and a CAGR of 29.7%. Key trends include shifting from model novelty to execution-focused platforms, leveraging AI for target identification, and lead optimization. Partnerships and regulatory shifts enhance adoption and credibility.

Emerging hotspots like North America and Europe are leading due to strong regulatory frameworks and compute access. Technology convergence, such as multimodal AI and lab automation, accelerates cycle times. Firms prioritizing proprietary data and closed-loop experimentation will gain competitive advantage, driving significant industry transformation by 2030.

AI-Driven Drug Discovery Platforms Market Disruption.

Perspective.

Anagha Nikam

1What is the main purpose of AI in drug discovery?

2What are the key regions covered in the report?

3How does AI contribute to regulatory compliance in drug discovery?

4What are the emerging technologies in AI-driven drug discovery?

5Why is collaboration important in AI drug discovery?

Summary.